Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-09-20FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for levetiracetam submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-09-20FDA Approved: PRIMIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Primidone submitted by Dr. Reddy's Laboratories Limited. This action concerns a generic version …
-
CLINICAL_TRIALS research · 2011-09-20Clinical Trial Update: Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers
Clinical trial update evaluating the safety and feasibility of using Epicall to monitor pre-seizure biomarkers.
-
FDA approval · 2011-09-15FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves a supplemental application for LEVETIRACETAM from Lupin Pharmaceuticals, Inc. This is a supplemental approval for the generic p…
-
FDA approval · 2011-09-13FDA Approved: FELBAMATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the original ANDA for felbamate from Amneal Pharmaceuticals of New York LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-09-12FDA Approved: LEVETIRACETAM — Original Application (Apotex Corp.)
FDA approves the original application for a generic levetiracetam (Apotex Corp.), enabling a generic version of the anticonvulsant for seizu…
-
FDA approval · 2011-09-12FDA Approved: LEVETIRACETAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic version of levetiracetam through an Original Application (ANDA), adding a generic option for thi…
-
CLINICAL_TRIALS trial_result · 2011-09-09Clinical Trial Update: Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of lacosamide in patients with partial seizures has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy [Phase 4]
Open-label Phase 4 trial of zonisamide as adjunctive therapy in uncontrolled partial epilepsy completed with posted results.
-
FDA approval · 2011-08-30FDA Approved: OXCARBAZEPINE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved a supplemental application for oxcarbazepine from Breckenridge Pharmaceutical, Inc.
-
FDA approval · 2011-08-30FDA Approved: GABAPENTIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for gabapentin submitted by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2011-08-30FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Gabapentin from Aurobindo Pharma Limited under an approved ANDA.
-
FDA approval · 2011-08-29FDA Approved: GABAPENTIN — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Gabapentin from Exelan Pharmaceuticals, Inc. (ANDA 090705).
-
FDA approval · 2011-08-29FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for Gabapentin from BluePoint Laboratories, updating the existing approval for the generic product.
-
FDA label_change · 2011-08-29FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved a Gabapentin supplemental application from Granules Pharmaceuticals Inc.
-
FDA approval · 2011-08-22FDA Approved: CARBATROL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for CARBATROL (carbamazepine) filed by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures [Phase 3]
Phase 3 study evaluating the efficacy and safety of zonisamide and lamotrigine for refractory partial seizures with secondary generalization…
-
FDA approval · 2011-08-10FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc.
-
FDA approval · 2011-08-10FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for KEPPRA XR, approving an extended-release formulation of levetiracetam manufactured by UCB, I…
-
FDA approval · 2011-08-10FDA Approved: VIMPAT — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for VIMPAT (lacosamide) from UCB, Inc., updating the labeling and/or indications for this antiep…
-
FDA approval · 2011-08-05FDA Approved: LEVETIRACETAM — Original Application (Aryeh Pharma corp)
FDA approved Aryeh Pharma's generic version of levetiracetam under an original application (ANDA 091485). It is used to treat seizures in pe…
-
FDA approval · 2011-08-04FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL ODT (lamotrigine) submitted by GlaxoSmithKline LLC. The action updates the product's ap…
-
FDA approval · 2011-08-04FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for LAMICTAL XR (lamotrigine) from GlaxoSmithKline LLC, authorizing changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy [NA]
A completed pilot study evaluated the efficacy and tolerability of levetiracetam as monotherapy in children with childhood absence epilepsy.
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy
A completed clinical trial assessing hormonal side effects in epilepsy patients treated with levetiracetam, carbamazepine, or lamotrigine.